Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study. Issue 11 (17th March 2022)

• Record Type: Journal Article
• Authors: Yoo, Jung Eun; Han, Kyungdo; Shin, Dong Wook; Jung, Wonyoung; Kim, Dahye; Lee, Cheol Min; Kwon, Hyuktae; Jung, Kyu‐Won; Song, Yun‐Mi
• Is Part Of: Cancer. Volume 128:Issue 11(2022)
• Page Start: 2126
• Page End: 2137
• Publication Date: 2022-03-17
• Subjects: cancer -- cessation -- reduction -- resumption -- smoking; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.34172
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : Background: The objective of this study was to investigate the effects of reduction, cessation, and resumption of smoking on cancer development. Methods: The authors identified 893, 582 participants who currently smoked, had undergone a health screening in 2009, and had a follow‐up screening in 2011. Among them, 682, 996 participated in a third screening in 2013. Participants were categorized as quitters, reducers I (≥50% reduction), reducers II (<50% reduction), sustainers (referent), or increasers (≥20% increase). Outcome data were obtained through December 31, 2018. Results: Reducers I exhibited a decreased risk of all cancers (adjusted hazard ratio [aHR], 0.96; 95% confidence interval [CI], 0.93‐0.99), smoking‐related cancers (aHR, 0.95; 95% CI, 0.92‐0.99), and lung cancer (aHR, 0.83; 95% CI, 0.77‐0.88). Quitters had the lowest risk of all cancers (aHR, 0.94; 95% CI, 0.92‐0.96), smoking‐related cancers (aHR, 0.91; 95% CI, 0.89‐0.93), and lung cancer (aHR, 0.79; 95% CI, 0.76‐0.83). In further analysis with 3 consecutive screenings, additional smoking reduction (from reducers II to reducers I) lowered the risk of lung cancer (aHR, 0.74; 95% CI, 0.58‐0.94) in comparison with sustainers. Quitting among reducers I further decreased the risk of all cancers (aHR, 0.90; 95% CI, 0.80‐1.00), smoking‐related cancers (aHR, 0.81; 95% CI, 0.81‐0.92), and lung cancer (aHR, 0.66; 95% CI, 0.52‐0.84) in comparison with sustainers. Smoking resumption after quitting, even at a lower level, increased the risk of smoking‐related cancers (aHR, 1.19; 95% CI, 1.06‐1.33) and lung cancer (aHR, 1.48; 95% CI, 1.21‐1.80) in comparison with sustained quitting. Conclusions: Smoking cessation and, to a lesser extent, smoking reduction decreased the risks of cancer. Smoking resumption increased cancer risks in comparison with sustained quitting. Lay Summary: Worldwide, tobacco use is the single leading preventable risk factor for cancer and cancer death. This study examined the effects of reduction, cessation, and resumption of smoking on cancer development by measuring smoking behavior repetitively. Although smoking reduction has a substantial cancer prevention benefit for those who cannot quit, cessation should be encouraged whenever possible. Quitters should be monitored to ensure that they do not resume smoking. Abstract : Although smoking reduction has substantial cancer prevention benefits for those who cannot quit, cessation should be encouraged whenever possible. Quitters should be monitored to ensure that they do not resume smoking.